diff --git a/pages/STOP2030___Web.md b/pages/STOP2030___Web.md
index 1f30d920..de542b4c 100644
--- a/pages/STOP2030___Web.md
+++ b/pages/STOP2030___Web.md
@@ -13,6 +13,10 @@
 				- Develop a model for sustainable supply and costing
 				- Model the impact of different use cases and scenarios
 				- Pilot antihelmintic resistance surveillance based on genetic epidemiology
+		- ## Basic facts del proyecto
+			- En qué call de EDCTP (Global Health EDCTP3) ha salido
+			- Project duration (36 months); cuando empieza y cuando acaba (20 junio 2026)
+			-
 		- ## Timeline y milestones (cuáles se han cumplido?)
 			- __Proposed safety and effectiveness study__
 				- *Primary objective*: To evaluate and compare safety of a [[FDC]] against [[Albendazole]] alone via [[MDA]] in two study areas in Kenya and [[Ghana]].
@@ -46,9 +50,6 @@
 			- The access plan is being developed
 			- Integration across programs (these results have implications beyond STH)
 			- Progress has been achieved through public-private partnerships but more partners are needed to reach the ultimate goal.
-			- Project duration (36 months); cuando empieza y cuando acaba (20 junio 2026)
-		- ## Basic facts del proyecto
-			-
 		- ## Investigadores principales de cada uno de los partners
 		- ## Abstract del proyecto
 			- [[Soil-Transmitted Helminths]] (STH) remain a significant public health problem with recognized obstacles for control and elimination with the current benzimidazole regimens in [[Mass Drug Administration]] (MDA) campaigns. Renewed targets from [[WHO]] for 2030 include elimination of [[STH]] morbidity in pre-school and school age children (PSAC & SAC), increased country governance and financial support and a strongyloidiasis control program; 2030 has also been targeted by [[WHO]] for controlling NTDs to attain the Sustainable Development Goals.